Pande H, Campo K, Tanamachi B, Forman S J, Zaia J A
Division of Immunology, Beckman Research Institute of the City of Hope, Duarte, California, USA.
Scand J Infect Dis Suppl. 1995;99:117-20.
The 65 kDa tegument protein (pp65 or rather ppUL83) of human cytomegalovirus (HCMV) has been shown to be a major cytotoxic T-lymphocyte target during natural infection, and thus appears to be an appropriate candidate to be evaluated as a component of a HCMV polynucleotide vaccine. We have constructed expression vectors pH beta-pp65, in which pp65 expression is under the control of human beta-actin promoter, and pCMVint-pp65, in which pp65 expression is driven by the HCMV immediate-early promoter along with the intron A. These construct DNAs were utilized for the intramuscular injection into the quadriceps of BALB/c mice. Approximately 60% of the mice showed the presence of anti-pp65 antibodies following the second DNA inoculation with 100 micrograms of plasmid DNA. The anti-pp65 antibody titer was higher in the group of mice that was injected with pCMVint-pp65 plasmid DNA compared to the group that was injected with pH beta-pp65 DNA, presumably due to a higher level of pp65 expression using the former plasmid.
人巨细胞病毒(HCMV)的65 kDa被膜蛋白(pp65或更确切地说是ppUL83)已被证明是自然感染期间主要的细胞毒性T淋巴细胞靶点,因此似乎是作为HCMV多核苷酸疫苗成分进行评估的合适候选物。我们构建了表达载体pH beta-pp65(其中pp65的表达受人类β-肌动蛋白启动子控制)和pCMVint-pp65(其中pp65的表达由HCMV立即早期启动子以及内含子A驱动)。这些构建的DNA被用于肌肉注射到BALB/c小鼠的股四头肌中。在用100微克质粒DNA进行第二次DNA接种后,约60%的小鼠显示出抗pp65抗体的存在。与注射pH beta-pp65 DNA的小鼠组相比,注射pCMVint-pp65质粒DNA的小鼠组中的抗pp65抗体滴度更高,这可能是由于使用前一种质粒时pp65的表达水平更高。